MethylGene raises $20 million

Cancer and infectious disease company MethylGene (TSX:MYG) raised US$20 million in a private placement of 7.4 million units at US$3.10. Each unit consists of a share and 0.3 warrants, with each whole warrant exercisable at US$3.90, US$4.10 and US$4.25 after one, two and three years. Investors were led by ProQuest Investments and included Domain Public Equity; CIBC; Pappas Ventures; and certain existing investors, including Fonds de solidarite des travailleurs du Quebec. ...